ProtoKinetix Inc Sustainability Reports
ProtoKinetix, Incorporated is a clinical-stage biomedical research and development company focused on cell survival solutions. The company develops applications for its patented anti-aging glycopeptide (AAGP) molecule within ophthalmology, dermatology, biomanufacturing, and transplantation medicine.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001SK0VN8
No reports are currently available in our catalogue.